Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- USD | -.--% | -4.49% | -0.54% |
2022 | Novelion Therapeutics Inc. Announces Final Cash Distribution, Payable on or About March 31, 2022 | CI |
2020 | Novelion Therapeutics Inc. Announces Management Changes | CI |
Sales 2017 | 138.44 189.23 | Sales 2018 | 130.43 178.29 | Capitalization | 15.9M 21.74M |
---|---|---|---|---|---|
Net income 2017 | -127M -174M | Net income 2018 | -108M -148M | EV / Sales 2017 | 1,887,512 x |
Net Debt 2017 | 203M 278M | Net Debt 2018 | 303M 415M | EV / Sales 2018 | 2,447,567 x |
P/E ratio 2017 |
-0.46
x | P/E ratio 2018 |
-0.15
x | Employees | - |
Yield 2017 * |
-
| Yield 2018 |
-
| Free-Float | 0% |
- Stock Market
- Equities
- NVLNF Stock